• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Assessment of risk by biological monitoring.通过生物监测评估风险。
Br J Ind Med. 1981 May;38(2):198-201. doi: 10.1136/oem.38.2.198.
2
Polymorphism in drug metabolism--implications for drug toxicity.
Arch Toxicol Suppl. 1986;9:138-46. doi: 10.1007/978-3-642-71248-7_16.
3
Trends in human risk assessment of pharmaceuticals.药品人体风险评估的趋势。
Anal Bioanal Chem. 2007 Feb;387(4):1167-72. doi: 10.1007/s00216-006-0961-9. Epub 2007 Jan 5.
4
The implementation of medical monitoring programs following potentially hazardous exposures: a medico-legal perspective.潜在危险暴露后医学监测计划的实施:法医学视角
Clin Toxicol (Phila). 2017 Nov;55(9):956-969. doi: 10.1080/15563650.2017.1334913. Epub 2017 Jun 23.
5
In response: governmental perspective.回应:政府视角。
Environ Toxicol Chem. 2014 Sep;33(9):1918-20. doi: 10.1002/etc.2668.
6
Effects of addictive substances during pregnancy and infancy and their analysis in biological materials.孕期和婴儿期成瘾物质的影响及其在生物材料中的分析。
Rev Environ Contam Toxicol. 2014;227:55-77. doi: 10.1007/978-3-319-01327-5_2.
7
An integrated approach for prioritizing pharmaceuticals found in the environment for risk assessment, monitoring and advanced research.一种用于对环境中发现的药品进行风险评估、监测和深入研究的优先级排序的综合方法。
Chemosphere. 2014 Nov;115:4-12. doi: 10.1016/j.chemosphere.2014.01.021. Epub 2014 Mar 15.
8
Pharmaceuticals in the environment--a human risk?环境中的药物——对人类有风险吗?
Regul Toxicol Pharmacol. 1998 Dec;28(3):212-21. doi: 10.1006/rtph.1998.1253.
9
Progressing the utilisation of pharmacogenetics and pharmacogenomics into clinical care.推进药物遗传学和药物基因组学在临床护理中的应用。
Pathology. 2013 Jun;45(4):357-70. doi: 10.1097/PAT.0b013e328360b66e.
10
Environmental risk assessment of medicinal products for human use according to European Commission recommendations.根据欧盟委员会的建议对人用药品进行环境风险评估。
Environ Toxicol. 2004 Jun;19(3):226-40. doi: 10.1002/tox.20015.

引用本文的文献

1
Review of pesticide urinary biomarker measurements from selected US EPA children's observational exposure studies.美国环保署选择的儿童观察性暴露研究中农药尿生物标志物测量的综述。
Int J Environ Res Public Health. 2011 May;8(5):1727-54. doi: 10.3390/ijerph8051727. Epub 2011 May 24.
2
Residual cognitive deficits 50 years after lead poisoning during childhood.儿童期铅中毒50年后的残留认知缺陷。
Br J Ind Med. 1993 Jul;50(7):613-22. doi: 10.1136/oem.50.7.613.
3
Metallothionein and occupational exposure to cadmium.金属硫蛋白与职业性镉暴露
Br J Ind Med. 1983 Aug;40(3):305-13. doi: 10.1136/oem.40.3.305.

本文引用的文献

1
Use of breath analysis to monitor methylene chloride exposure.使用呼吸分析监测二氯甲烷暴露情况。
Scand J Work Environ Health. 1976 Jun;2(2):57-70. doi: 10.5271/sjweh.2817.
2
Trichloroethylene exposure. Simulation of uptake, excretion, and metabolism using a mathematical model.三氯乙烯暴露。使用数学模型模拟吸收、排泄和代谢。
Br J Ind Med. 1977 Feb;34(1):43-55. doi: 10.1136/oem.34.1.43.
3
The predictable relationship between plasma levels and dose during chronic propranolol therapy.
Clin Pharmacol Ther. 1978 Dec;24(6):668-77. doi: 10.1002/cpt1978246668.
4
N-acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark.N-乙酰转移酶表型与膀胱癌风险:分子流行病学方法。瑞典和丹麦的初步结果。
Environ Health Perspect. 1979 Apr;29:71-9. doi: 10.1289/ehp.792971.
5
Regulation of drug metabolism in man by environmental factors.
Drug Metab Rev. 1979;9(2):185-205. doi: 10.3109/03602537908993890.
6
Genetic and environmental factors affecting drug disposition in man.
Clin Pharmacol Ther. 1977 Nov;22(5 Pt 2):659-79. doi: 10.1002/cpt1977225part2659.
7
Renal excretion of proteins and enzymes in workers exposed to cadmium.镉接触工人的蛋白质和酶的肾排泄情况。
Eur J Clin Invest. 1979 Feb;9(1):11-22. doi: 10.1111/j.1365-2362.1979.tb01662.x.

通过生物监测评估风险。

Assessment of risk by biological monitoring.

作者信息

Gompertz D

出版信息

Br J Ind Med. 1981 May;38(2):198-201. doi: 10.1136/oem.38.2.198.

DOI:10.1136/oem.38.2.198
PMID:7236547
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1008848/
Abstract

Variability between workers is reflected in differences in uptake, metabolism, and excretion of toxic substances, and thus individual response to toxic hazards. It is argued that biological monitoring takes account of these differences enabling individual risk assessments to be made. Risk, however, must be seen in terms of clinical and pathological changes-that is, estimated from morbidity and mortality rates-and so laboratory measurements need to be linked to epidemiological studies before they can be used to indicate acceptable or unacceptable uptake of toxic materials.

摘要

工人之间的差异体现在有毒物质的吸收、代谢和排泄的不同上,进而反映在个体对有毒危害的反应上。有人认为生物监测考虑到了这些差异,从而能够进行个体风险评估。然而,风险必须从临床和病理变化的角度来看待,也就是说,要根据发病率和死亡率来估计,因此在实验室测量结果能够用于表明有毒物质的摄入是否可接受之前,需要将其与流行病学研究联系起来。